Binance experienced a significant net inflow of 59,748,800 USDT within a one-hour period, highlighting intense short-term trading activity involving the stablecoin. This inflow reflects strong demand or movement of stablecoin assets on the exchange, which could indicate increased trading volume or liquidity shifts. Monitoring such flows helps investors gauge market sentiment and potential price impacts in the digital asset space.
Binance USDT net inflow shows 59.7488 million USDT moved in one hour, indicating active stablecoin trading. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 06, 2026 12:41 WIB: out of 50 major cryptocurrencies, 23 rose and 25 fell. Notable movers include SAND at Rp1.171 with a -9.84% change, EOS at Rp12.649 up 8.13%, and ATOM at Rp32.381 rising 4.45%.
Ethereum (ETH) maintained stability above $2,700, marking its first weekly close above this level in nine months, signaling renewed bullish sentiment. Treasury firm BitMine expanded its Ethereum holdings by 15,112 ETH, now controlling about 4.9% of t...
Bitcoin options markets have shifted toward a bullish stance, with one-week 25-delta call options now more in demand than puts, indicating traders expect price gains. This shift, first seen in August 2026, shows calls making up about 61.4% of open in...
Binance experienced a net outflow of approximately 40,000 Bitcoin over a 15-day period, reducing its reserves from 704,800 BTC to 663,100 BTC. The weekly net outflow hit 23,100 BTC, the highest since June 2023, with a daily peak of 14,300 BTC on Octo...
Nebius Group N.V. is rated a buy due to its strategic partnership with Palantir, which positions Nebius as the preferred sovereign infrastructure provider for Palantir's enterprise AI solutions targeting regulated industries. This collaboration allow...
Poolbeg Pharma has obtained a South Korean patent for POLB 001, a treatment designed to prevent cytokine release syndrome (CRS), a serious side effect of cancer immunotherapy. The patent covers the use of p38 MAP kinase inhibitors to prevent CRS and ...
